Who owns ZENAS BIOPHARMA INC?
- CUSIP Number: 98937laa3
Tip: Access positions for across all investors
Analyze quarterly positions in Zenas Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Zenas Biopharma stock
Who bought or sold ZENAS BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deerfield Management Company | 67M | $80M | 3% | Jun 2026 |
|
| Linden Advisors | 36M | $43M | 379% | Jun 2026 |
|
| Context Capital Management | 36M | $43M | 23% | Jun 2026 |
|
| Citadel Advisors | 22M | $26M | 171% | Jun 2026 |
|
| Highbridge Capital Management | 20M | $20M | 100% | Mar 2026 |
|
| Readystate Asset Management | 6.5M | $7.7M | 100% | Jun 2026 |
|
| Jane Street | 6.5M | $7.8M | -32% | Jun 2026 |
|
| Leucadia National Corporation | 5.0M | $6.0M | -10% | Jun 2026 |
|
| Capstone Investment Advisors | 3.5M | $4.2M | 0% | Jun 2026 |
|
| Woodline Partners | 2.5M | $3.0M | 0% | Jun 2026 |
|
| Graham Capital Management | 2.5M | $3.0M | 0% | Jun 2026 |
|
| Advent Capital Management | 2.4M | $2.8M | 100% | Jun 2026 |
|
| Agf Management | 1.2M | $1.4M | 100% | Jun 2026 |
|
| Millennium Management | 200k | $239k | -83% | Jun 2026 |
|
| SG Americas Securities | 16k | $2.0M | 100% | Jun 2026 |
|
Who sold out of Zenas Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jpmorgan Chase & Co | Mar 2026 | 20M | $20M |
| Braidwell | Mar 2026 | 13M | $14M |
| Monashee Investment Management | Mar 2026 | 3.2M | $3.2M |
| D. E. Shaw & Co | Mar 2026 | 3.0M | $3.1M |
| Calamos Advisors | Mar 2026 | 2.5M | $2.6M |
| Maven Securities | Mar 2026 | 1.5M | $1.6M |
| Aristeia Capital | Mar 2026 | 500k | $518k |